期刊文献+

促红细胞生成素治疗急性心肌梗死的研究进展

下载PDF
导出
摘要 促红细胞生成素对于心血管系统的保护作用逐渐成为研究热点,基础研究及单中心临床试验已经初步观察到促红细胞生成素治疗动物缺血再灌注损伤和急性心肌梗死的临床疗效。本文综述促红细胞生成素治疗急性心肌梗死的机制、疗效与安全性,认识其对心血管终点事件等的影响和可能的血液学等副作用,以促进促红细胞生成素的合理应用,为急性心肌梗死等相关心血管系统疾病的治疗带来新的方法和思路。
出处 《国外医学(老年医学分册)》 2008年第3期118-121,共4页 Foreign Medical Sciences(Geriatrics)
基金 北京科委基金资助课题(D0906004000091)
  • 相关文献

参考文献26

  • 1Fliser D, Bahlmann FH, deGroot K et al. Mechanisms of disease: erythropoietin an old hormone with a new mission? Nat Clin Pratt Cardiovasc Med, 2006; 3 (10): 563 - 572
  • 2Lipsic E, Schoemaker RG, van der Meet P. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J Am Coll Cardiol, 2006; 48 (11) : 2161 -7216
  • 3Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med, 2003; 228:1 - 14
  • 4郭玲,王爱红,吕琳,鹿克风,孙永乐.EPO辅助治疗慢性心力衰竭合并贫血52例临床观察[J].山东医药,2007,47(5):57-58. 被引量:10
  • 5骆雷鸣,李妍涵,顾杰,刘丽,杨雪,朱兵,曾强,陈敏芝,吴红梅,叶平.促红细胞生成素对慢性心衰患者血栓风险的影响[J].药物不良反应杂志,2007,9(1):14-17. 被引量:5
  • 6吴海云,赵玉生,许强,朱姝.促红细胞生成素对慢性心衰并贫血患者运动贮量的作用[J].心血管康复医学杂志,2005,14(2):106-108. 被引量:1
  • 7Meer P, Voors AA, Lipsic E et al. Erythropoietin in cardiovascular diseases. Eur Heart J, 2004; 25 (4) : 285 ,291
  • 8Kristensen J, Henrik S, Michael Met al. Acute haemodynamic effects of erythropoietin alone and in combination with dopamine in a porcine model. Clinical Physiology Functional imaging, 2006; 26 (5) : 283 - 287
  • 9Silverberg DS, Wexler D, Sheps D et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin an intravenous iron: a randomized controlled study. J Am Coll Cardiol, 2001 ; 37 : 1775 - 1780
  • 10Rafiee P, Shi Y, Su Jet al, Erythropoietin protects the infant heart against ischemia - reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol, 2005 ; 100 (3): 187-197

二级参考文献16

  • 1Wexsler D,Silverberg D,Sheps D,et al.The importance of correction of anemia witherythropoietin and intravenous iron in severe resistant congestive heart failure[J].The European Journal of Heart Failure,2003(Supl):225-230.
  • 2Mancini DM,Katz SD,Lang CC,et al.Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure[J].Circulation,2003,107:294-299.
  • 3Ezekowitz JA,McAlister FA,Armstrong PW.Anemia is common in heart failure and is associated with poor outcomes[J].Circulation,2003,107:223-225.
  • 4Smith KJ,Bleyer AJ,Little WC,et al.The cardiovascular effects of erythropoietin[J].Cardiovascular Research,2003,59(9):538.
  • 5Besarab A,Bolton WK,Browne JK,et al.The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and erythropoietin[J].N Engl J Med,1998,27(9):584-590.
  • 6Adamson JW,Vapnek D.Recombinant erythropoietin to improve athletic performance[J].N Engl J Med,1991,324:698-699.
  • 7Caiola K,Cheng JW.Use of erythropoietin in heart failure management[J].Ann Pharmacother,2004,38(12):2145-2149.
  • 8Silverberg DS,Wexler D,Shep SD,et al.The effect of connection of mild anemia in severe,resistant congestive heart failure using subcutaneous Erythropoietin and intravenous iron:a randomized controlled study[J].J Am Coll Cardiol,2001,37(7):1775-1780.
  • 9van derMeer P,Voors AA,Lipsie E,et al.Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure[J].J Am coll Cardiol,2004,44(1):63-67.
  • 10Tang YD, Katz SD. Treatment options anemia in chronic heart failure: prevalence, etiology, clinical correlates,and treatment options [J]. Circulation, 2006, 113 (4):2454-2461.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部